icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
Non-adherence is the most important risk factor for
ledipasvir/sofosbuvir HCV treatment failure in the real world

 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
Dost Sarpel, Isaac Wasserman, Alyssa Trochtenberg, Kian Bichoupan, David DelBello, Ponni V Perumalswami, Alyson Harty, Daniel Fierer, Michael Mullen, Douglas Dieterich, Andrea D. Branch
Icahn School of Medicine at Mount Sinai, New York, NY, United States

HIV1

HIV2

HIV3

HIV4

HIV5